← Evidence map

ReviewFrontiers in immunology2014

Immunological Markers for PML Prediction in MS Patients Treated with Natalizumab.

Caroline Antoniol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

16 papers cite it

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 25601865